Summary of Key Points Core Viewpoint - Tianyuan Medical (00557.HK) anticipates a significant decline in total revenue for the six months ending June 30, 2025, projecting approximately HKD 8.4 million, a decrease of about 44% compared to approximately HKD 14.9 million for the previous period [1][3]. Revenue Decline Reasons - The primary reason for the expected revenue decrease is the suspension of operations and renovations at Shanghai Yuyue Weilai Medical Beauty Hospital, which is partially owned by the group. This is expected to result in a revenue drop of no less than approximately HKD 6.2 million, reducing medical business revenue to about HKD 0.5 million (previous period: approximately HKD 6.7 million) [3]. Net Loss Projection - The company projects a net loss of approximately HKD 8.4 million for the interim period, compared to a net loss of approximately HKD 9 million for the previous period. This anticipated loss is primarily attributed to the estimated decrease in total revenue, offset by a corresponding reduction in operating costs [3]. Business Overview - Tianyuan Medical's main business activities include investment holding, providing procurement, marketing, management, franchising, and plastic surgery services to the medical industry, as well as lending and related services, and offering procurement services to the hotel industry [3].
天元医疗(00557.HK)：预期中期总收益减少约44%